Plain-English translation of NCT05007340 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a research registry and tissue bank designed to help scientists better understand interstitial lung disease (ILD)—a serious lung condition—in people who have autoimmune rheumatic diseases like rheumatoid arthritis, lupus, scleroderma, and autoimmune myositis. Researchers will collect blood samples, lung tissue when available, and medical information from about 250 participants to study why some autoimmune patients develop lung damage and others don't.
Many people with autoimmune diseases develop lung inflammation that can be disabling or life-threatening, but doctors still don't fully understand who is at highest risk or what causes it. This study aims to fill those gaps by building a resource that will help scientists develop better ways to predict, prevent, and treat lung disease in autoimmune patients.
You likely qualify if…
You likely don't qualify if…
As a participant, you would donate blood samples and possibly tissue samples (if a lung biopsy is already being done for your care), and allow researchers to access your medical records and imaging scans. You may be asked to complete surveys or questionnaires about your symptoms and medical history. The study does not involve taking a new medication—it's focused on collecting samples and information to help scientists understand the disease better.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
Canada